A PERSPECTIVE ON ANTIINFECTIVE AGENTS INTERACTION IN HUMAN IMMUNODEFICIENCY VIRUS PATIENTS WITH MALARIAL INFECTION

Authors

  • Girish M Bhopale Girish M. BhopaleDr. D. Y. Patil Biotechnology & Bioinformatics Institute,Dr. D.Y. Patil Vidhyapeeth,Tathawade, Pune, 411033, MS, India

Abstract

ABSTRACT
Despite recent research advances in anti-infective agents (achievements), Human immunodeficiency virus (HIV), and malaria infection are currently
considered two main global human health problems. Given the considerable geographical overlap between malaria and HIV, a substantial number of
co-infection incidences occur in human. The purpose of this review is to summarize the information on the clinical impact of co-infection, therapeutic
anti-infective agents' interaction in human and future research priorities.
Keywords: Malaria, Human immunodeficiency virus, Co-infection, Anti-malarial drug and anti-retroviral drug interaction, Public health, Clinical
epidemiology, Anti-infective agents.

Downloads

Download data is not yet available.

Author Biography

Girish M Bhopale, Girish M. BhopaleDr. D. Y. Patil Biotechnology & Bioinformatics Institute,Dr. D.Y. Patil Vidhyapeeth,Tathawade, Pune, 411033, MS, India

Dept. Biotechnology

Associate Professor

References

REFERENCES

Hochman S, Kim K. The impact of HIV and Malaria co-infection: What

is known and suggested venues for further study. Interdiscip Perspect

Infect Dis 2009;2009:617954.

Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and

malaria fuels the spread of both diseases in sub-Saharan Africa. Science

;314(5805):1603-6.

Available from: http://www.who.int/malaria/areas/high_risk_groups/

hiv_aids_patients/en/. [Last accessed on 2014 Nov 24].

Nkuo-Akenji T, Tevoufouet EE, Nzang F, Fon E, Ebong IN. HIV/AIDS

and malaria in pregnant women from Cameroon short running title:

HIV, malaria in pregnancy. Afr J Health Sci 2011;18:105-9.

Bhopale GM. Emerging drugs for the treatment of human

immunodeficiency virus. Recent Pat Antiinfect Drug Discov

;7:45-52.

The global malarial epidemic. Kaiser Family Foundation Files.

Available from: http://www. worldprocess.com/2012/10/7882-04-pdf.

[Last accessed on 2014 Apr 04].

The global HIV/AIDS epidemic, Kaiser Family foundazation. Files.

Available from: http://www.wordpress.com/2013/10/3030/17-globalhiv.pdf.

[Last accessed on 2014 Apr

.

Zafar KS, Kumar A, Haque SF. HIV-Malaria: An emerging challenge

for the mankind. Int J Res Health Sci 2014;2(4):1143-9.

Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, et al. Effect

of Plasmodium falciparum Malaria on concentration of HIV-1-RNA in

the blood of adults in rural Malawi: A prospective cohort study. Lancet

;365(9455):233-40.

Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection

on malaria and therapeutic implications: A systematic review. Lancet

Infect Dis 2011;11(7):541-56.

Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, Williams TN,

et al. HIV infection among children with severe malaria. Clin Infect Dis

;49(3):336-43.

Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions

between HIV and malaria in non-pregnant adults: Evidence and

implications. AIDS 2006;20(16):1993-2004.

Focà E, Odolini S, Brianese N, Carosi G. Malaria and HIV in

adults:When the parasite runs into the virus. Mediterr J Hematol Infect

Dis. 2012:4(1)e2012032.

Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al.

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood

plasma concentration. AIDS 1999;13(4):487-94.

Devenport GC, Ouma C, Hitter JB, Were T, Ouma Y, Ong’echa JM,

et al. Hematological predictors of increased severe anemia in Kanyan

children coinfected with Plasmodium falciparum and HIV-1. Am J

Hematol 2010;85(4):227-33.

Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C,

et al. Maternal malaria and perinatal HIV transmission, western Kenya.

Emerg Infect Dis 2004;10(4):643-52.

Fehintola FA, Akinyinka OO, Adewole IF, Maponga CC, Ma Q, Morse

FD. Drug interactions in the treatment and chemoprophylaxis of

malaria in HIV infected individuals in sub-Saharan Africa. Curr Drug

Metab 2111;12(1):51-6.

Kredo T, Mauff K, Van der Walt JS, Wiesner L, Maartens G, Cohen K,

et al. Interaction between artemether–lumefantrine and nevirapine

based antiretroviral therapy in HIV-1 infected patients. Antimicrob

Agents Chemother 2011;55(12):5616-23.

Byakika-Kibwika P, Lamorde M, Mayito J, Nabukeera L, Namakula R,

Mayanja-Kizza H, et al. Significant pharmacokinetic interactions

Asian J Pharm Clin Res, Vol 9, Issue 4, 2016, 15-17

Bhopale

between artemether/lumefantrine and efavirenz or nevirapine in HIV –

Infected Uganda adults. J Antimicrob Chemother 2012;67(9):2213-21.

Van Geertruyden JP. Interactions between malaria and human

immunodeficiency virus anno 2014. Clin Microbiol Infect

;20(4):278-85.

Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, et al.

Antiretroviral agents and prevention of malaria in HIV-infected

Ugandan children. N Engl J Med 2012;367(22):2110-8.

Savarino A, Lucia MB, Rastrelli E, Rutella S, Golotta C, Morra E,

et al. Anti-HIV effects of chloroquine: Inhibition of viral particle

glycosylation and synergism with protease inhibitors. J Acquir Immune

Defic Syndr 2004;35(3):223-32.

Manyando C, Njunju EM, D’ Alessandro U, van Geertruyden JP.

Safety and efficacy of co-trimoxazole for treatment and prevention

of Plasmodium falciparum malaria: A systematic review. PLoS One

;8(2):e56916.

Published

01-07-2016

How to Cite

Bhopale, G. M. “A PERSPECTIVE ON ANTIINFECTIVE AGENTS INTERACTION IN HUMAN IMMUNODEFICIENCY VIRUS PATIENTS WITH MALARIAL INFECTION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 4, July 2016, pp. 15-17, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11374.

Issue

Section

Review Article(s)